Private Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
27,491
-316
-1% -$18.1K 0.13% 176
2026
Q1
$1.69M Sell
27,807
-419
-1% -$24.4K 0.15% 146
2025
Q4
$1.52M Sell
28,226
-619
-2% -$29.8K 0.13% 170
2025
Q3
$1.3M Sell
28,845
-1,845
-6% -$86.2K 0.11% 199
2025
Q2
$1.42M Sell
30,690
-1,139
-4% -$55.9K 0.14% 165
2025
Q1
$1.94M Sell
31,829
-1,514
-5% -$88.3K 0.2% 108
2024
Q4
$1.89M Sell
33,343
-605
-2% -$33.8K 0.19% 116
2024
Q3
$1.76M Sell
33,948
-3,531
-9% -$166K 0.18% 126
2024
Q2
$1.56M Sell
37,479
-3,173
-8% -$142K 0.17% 127
2024
Q1
$2.2M Sell
40,652
-1,951
-5% -$99.4K 0.24% 89
2023
Q4
$2.19M Sell
42,603
-4,087
-9% -$215K 0.26% 84
2023
Q3
$2.71M Sell
46,690
-2,883
-6% -$177K 0.36% 54
2023
Q2
$3.17M Sell
49,573
-766
-2% -$51.4K 0.4% 48
2023
Q1
$3.49M Buy
50,339
+1,307
+3% +$92.2K 0.48% 37
2022
Q4
$3.53M Sell
49,032
-1,476
-3% -$111K 0.52% 28
2022
Q3
$3.59M Sell
50,508
-2,519
-5% -$183K 0.58% 28
2022
Q2
$4.08M Buy
53,027
+492
+0.9% +$37.5K 0.63% 23
2022
Q1
$3.84M Sell
52,535
-2,610
-5% -$175K 0.6% 41
2021
Q4
$3.44M Buy
55,145
+3,056
+6% +$179K 0.47% 51
2021
Q3
$3.08M Buy
52,089
+7,467
+17% +$492K 0.45% 54
2021
Q2
$2.98M Sell
44,622
-215
-0.5% -$14K 0.45% 53
2021
Q1
$2.83M Buy
44,837
+559
+1% +$34.8K 0.46% 55
2020
Q4
$2.75M Sell
44,278
-682
-2% -$41.9K 0.46% 56
2020
Q3
$2.71M Buy
44,960
+1,467
+3% +$88.3K 0.52% 50
2020
Q2
$2.62M Buy
43,493
+2,088
+5% +$125K 0.55% 46
2020
Q1
$2.31M Sell
41,405
-793
-2% -$48.5K 0.6% 45
2019
Q4
$2.71M Buy
42,198
+6,363
+18% +$364K 0.5% 53
2019
Q3
$1.82M Sell
35,835
-2,081
-5% -$97.8K 0.36% 78
2019
Q2
$1.72M Sell
37,916
-1,096
-3% -$51.1K 0.35% 78
2019
Q1
$1.86M Buy
39,012
+141
+0.4% +$7.02K 0.39% 68
2018
Q4
$2.02M Sell
38,871
-7,671
-16% -$412K 0.48% 54
2018
Q3
$2.89M Sell
46,542
-1,114
-2% -$66.1K 0.59% 39
2018
Q2
$2.64M Sell
47,656
-15,182
-24% -$820K 0.57% 43
2018
Q1
$3.97M Buy
62,838
+841
+1% +$54.1K 0.87% 22
2017
Q4
$3.8M Sell
61,997
-1,991
-3% -$125K 0.8% 27
2017
Q3
$4.08M Sell
63,988
-36
-0.1% -$2.1K 0.89% 23
2017
Q2
$3.57M Sell
64,024
-7,872
-11% -$428K 0.78% 28
2017
Q1
$3.91M Sell
71,896
-1,270
-2% -$69.7K 0.9% 22
2016
Q4
$4.28M Sell
73,166
-226
-0.3% -$12.4K 1.02% 20
2016
Q3
$3.96M Buy
73,392
+10,246
+16% +$658K 0.96% 22
2016
Q2
$4.64M Sell
63,146
-3,675
-5% -$260K 1.21% 15
2016
Q1
$4.27M Buy
66,821
+2,147
+3% +$135K 1.16% 17
2015
Q4
$4.45M Sell
64,674
-282
-0.4% -$18.6K 1.27% 15
2015
Q3
$3.85M Buy
64,956
+1,107
+2% +$70.2K 1.15% 14
2015
Q2
$4.25M Buy
63,849
+2,951
+5% +$194K 1.22% 14
2015
Q1
$3.93M Buy
60,898
+9,029
+17% +$565K 1.12% 17
2014
Q4
$3.06M Buy
51,869
+8,846
+21% +$499K 0.97% 18
2014
Q3
$2.2M Sell
43,023
-1,149
-3% -$57.4K 0.75% 22
2014
Q2
$2.14M Buy
44,172
+9,011
+26% +$444K 0.7% 28
2014
Q1
$1.83M Sell
35,161
-618
-2% -$32.9K 0.69% 30
2013
Q4
$1.9M Sell
35,779
-39,787
-53% -$2.03M 0.77% 27
2013
Q3
$3.5M Buy
75,566
+13,475
+22% +$592K 1.58% 6
2013
Q2
$2.77M Buy
+62,091
New +$2.7M 1.27% 9

Other funds holding BMY

Private Trust Company's BMY Position: Q2 2026 in Review

Private Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, selling an estimated $18.1K and leaving 27,491 shares worth $1.58M. The position accounts for 0.13% of the portfolio, ranked #176.

Private Trust Company first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.64M in Q2 2016. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Private Trust Company held 27,491 shares of Bristol-Myers Squibb worth $1.58M as of Q2 2026.
  • Private Trust Company sold 316 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.1K.
  • Bristol-Myers Squibb made up 0.13% of Private Trust Company's portfolio in Q2 2026, its #176 holding.
  • Private Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Private Trust Company's Bristol-Myers Squibb position peaked at $4.64M in Q2 2016.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.